Výsledky vyhledávání - "M. T. Barletta"

A retrospective analysis of patients (pts) with non-small-cell lung cancer (NSCLC) with uncommon or complex epidermal growth factor receptor (EGFR) mutations treated with tyrosine kinase inhibitors (EGFR-TKIs): clinical features and outcome

Autor: L. Fornaro, A. Farnesi, G. Puppo, Riccardo Giannini, Giulia Pasquini, Antonio Chella, Enrico Vasile, Chiara Caparello, I. Stasi, M. Luccchesi, M. T. Barletta, A. Falcone, Elisa Sensi, Cristiana Lupi, C. Finale, Giacomo Allegrini, Gabriella Fontanini, Iacopo Petrini

Publikováno v: Annals of Oncology. 28:vi56

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::56ef12908a1e5c20bdcf78ee88c4bff3
https://doi.org/10.1093/annonc/mdx426.006

Zobrazit plný text záznamu

METRONOMIC CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH ADVANCED, CASTRATION-RESISTANT PROSTATE CANCER

Autor: Gabriele Minuti, S. Bursi, Lisa Derosa, Lorenza Landi, Luca Galli, E. Bona, Guido Bocci, Ilaria Grazzini, M. D'Arcangelo, Romano Danesi, Alfredo Falcone, M. T. Barletta, Paola Orlandi, Anna Fioravanti, Andrea Fontana

Publikováno v: Journal of the American Geriatrics Society. 58:986-988

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d019cffc245d7538de05ba40030da11d
https://doi.org/10.1111/j.1532-5415.2010.02833.x

Zobrazit plný text záznamu

Discordant somatic and germline VEGF-A genotype in a cancer patient resistant to paclitaxel/bevacizumab with chemosensitive hepatic metastasis

Autor: Paola Orlandi, Romano Danesi, Luigi Coltelli, Giacomo Allegrini, Anna Fioravanti, Mario Del Tacca, Guido Bocci, Alfredo Falcone, N. Giuntini, M. T. Barletta, Gabriella Fontanini, Greta Alì, E. Bona

Publikováno v: Pharmacogenomics. 10(8)

Recent data reported an association between VEGF-A genotype of tumors and median overall survival as well as grade 3 or 4 hypertension when using bevacizumab in metastatic breast cancer. In the present case we report a discordant VEGF-A genotype betw

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3bfcf09a10d9a6def9d7accb5b69886
https://pubmed.ncbi.nlm.nih.gov/19663667

Zobrazit plný text záznamu

A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patients

Autor: Alfredo Falcone, M. T. Barletta, A. Di Paolo, M. Del Tacca, Romano Danesi, Giacomo Allegrini, Gianluca Masi, E. Cerri, Paola Orlandi, Anna Fioravanti, Guido Bocci, Fotios Loupakis, Robert S. Kerbel

Publikováno v: British Journal of Cancer

The pharmacokinetics (PK) and pharmacodynamics (PD) of metronomic irinotecan have not been studied in cancer patients. The aim of the study is to investigate the PK/PD profile of irinotecan/SN-38 administered by metronomic schedule. Twenty chemothera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ece9eda93b54213301fbc7a34e94c6
http://hdl.handle.net/11568/233996

Zobrazit plný text záznamu

The combination of capecitabine (C), irinotecan (I) and oxaliplatin (O) (XELOXIRI) as first line treatment of metastatic colorectal cancer (MCRC): Preliminary results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.)

Autor: Gianluca Masi, Andrea Antonuzzo, Fotios Loupakis, S. Bursi, Giacomo Giulio Baldi, Iacopo Petrini, C. Sonaglio, Alfredo Falcone, M. T. Barletta, Elisabetta Pfanner

Publikováno v: Università di Pisa-IRIS

4096 Background: FOLFOXIRI demonstrated manageable toxicities and improved activity and efficacy compared to FOLFIRI in MCRC in a phase III trial by the G.O.N.O. group. Oral C has demonstrated similar efficacy to 5-FU and might substitute 5-FU in the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227a727d9e77348ca25ecf3c47a0c13a
http://hdl.handle.net/11568/117051

Zobrazit plný text záznamu

3063 POSTER Capecitabine (C), in combination with irinotecan (I) and oxaliplatin (O) (XELOXIRI) as first-line treatment of metastatic colorectal cancer (MCRC): results of a pilot study by the Gruppo Oncologico Nord-Ovest (G.O.N.O.)

Autor: Silvana Chiara, Alfredo Falcone, M. T. Barletta, Elisabetta Pfanner, Giacomo Giulio Baldi, Gianluca Masi, Andrea Antonuzzo, Fotios Loupakis, S. Bursi, Iacopo Petrini

Publikováno v: European Journal of Cancer Supplements. 5:255

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f748ec5e56465ea60a51e3bc85b3919d
https://doi.org/10.1016/s1359-6349(07)70991-6

Zobrazit plný text záznamu

3067 POSTER Irinotecan Metronomic Chemotherapy (MC) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical, pharmacodynamic (PD) and pharmacokinetic (PK) evaluation

Autor: M. Del Tacca, Paola Orlandi, Romano Danesi, Anna Fioravanti, Guido Bocci, Giacomo Allegrini, Alfredo Falcone, M. T. Barletta, Fotios Loupakis, Giacomo Giulio Baldi

Publikováno v: European Journal of Cancer Supplements. 5:256

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c44566254a7025eb054e447df8831f45
https://doi.org/10.1016/s1359-6349(07)70995-3

Zobrazit plný text záznamu

Metronomic chemotherapy (MC) with irinotecan (CPT-11) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical and pharmacodynamic evaluation

Autor: Gianluca Masi, Guido Bocci, Giacomo Allegrini, Paola Orlandi, Alfredo Falcone, M. T. Barletta, Anna Fioravanti, E. Cerri, Fotios Loupakis, M. Del Tacca

Publikováno v: Università di Pisa-IRIS

13111 Background: Preclinical studies have demonstrated that the frequent administration of low doses of cytotoxic drugs over prolonged periods of time (MC) reduces tumour cell growth through inhibition of angiogenesis. The antitumor effect of a MC w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5ae17453cc5d2e69744f364ab0e3876
https://doi.org/10.1200/jco.2006.24.18_suppl.13111

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání